Understanding How E-ISA247 Binds to Cyclophilin A
Author Information
Author(s): Andreas Kuglstatter, Francis Mueller, Eric Kusznir, Bernard Gsell, Martine Stihle, Ralf Thoma, Joerg Benz, Launa Aspeslet, Derrick Freitag, Michael Hennig
Primary Institution: F. Hoffmann–La Roche, Discovery Technologies, Basel, Switzerland
Hypothesis
The study investigates the structural basis for the binding affinity and immunosuppressive potency of E-ISA247 compared to its stereoisomer Z-ISA247.
Conclusion
E-ISA247 has a higher binding affinity to cyclophilin A and greater immunosuppressive efficacy than Z-ISA247 and cyclosporin A.
Supporting Evidence
- E-ISA247 binds to cyclophilin A with a dissociation constant of 15 nM.
- Z-ISA247 has a higher dissociation constant of 61 nM, indicating weaker binding.
- The structural differences between E-ISA247 and Z-ISA247 affect their immunosuppressive efficacy.
Takeaway
E-ISA247 is a drug that works better than its sister drug Z-ISA247 because it fits better with a protein in our body that helps control the immune system.
Methodology
X-ray crystal structures of E-ISA247 and Z-ISA247 bound to cyclophilin A were determined, and their binding affinities were measured using fluorescence spectroscopy.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website